HVR Cardio is a medical device company focused on developing first-generation transcatheter mitral valve repair solutions. Our minimally invasive technology has the potential to enable safer, faster, and less traumatic cardiac interventions for mitral regurgitation patients worldwide. HVR Cradio’s innovative helix ring technology has been carefully designed to fit the anatomy of the mitral valve. This allows fast and easy implantation and most importantly, restoration of the valve geometry leading to uncompromised clinical efficacy. With our catheter-based product, we expect to reduce the invasiveness, operation time, and morbidity associated with mitral valve repair operations. This would allow effective treatment of patients at any stage of mitral valve disease, including those who currently have no treatment options. HVR FDardio’s patented helix ring technology, which is currently at an advanced development stage, can be applied to interventional cardiology as well as to cardiac surgery. For more information, please visit us at www.medtentia.com.
Location: Finland, Southern Finland Province, Espoo
Employees: 1-10
Total raised: $11.59M
Founded date: 2009
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.01.2023 | Series B | $11.59M | Innovestor |
Mentions in press and media 4
| Date | Title | Description |
| 16.01.2023 | Finland-based medical equipment startup HVR Cardio raises USD 11.1 million in Series B funding | Jan. 12, 2023 – HVR Cardio, a clinical-stage medical technology business creating Structural Heart cardiovascular solutions for transcatheter mitral valve replacement, announced today the completion of its 10.7 million Euro ($11.1 million U... |
| 16.01.2023 | Finnish medtech HVR Cardio raises €10.7M in a Series B round | Finnish medtech HVR Cardio raises €10.7M in a Series B round 16 January, 2023, 09:57 Mariia Denysiuk --> --> --> -->--> --> --> --> --> --> --> --> --> The Espoo-based medtech startup HVR Cardio has... |
| 12.01.2023 | HVR Cardio Raised $11.1M in Series B Financing | HVR Cardio, an Espoo, Finland-based cardiovascular device company, raised $11.1M in Series B funding. The round was led by Innovestor Life Science Fund and Tesi. The company intends to use the funds to accelerate growth and expand operation... |
| - | HVR Cardio | “HVR Cardio Transformative Mitral Valve Repair Solutions The Future of Mitral Valve Repair Our mission is to develop solutions for mitral valve interventions that are faster, easier to use, and less invasive without compromising clinical ef... |